查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2088792

獸藥市場：2026-2032年全球市場預測（依產品類型、目標動物、劑型、給藥途徑、疾病治療、最終用戶及通路分類）

Veterinary Medicine Market by Product Type, Animal Type, Product Form, Route Of Administration, Disease Treatment, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，獸藥市場規模將達到 849.1 億美元，複合年成長率為 8.13%。

主要市場統計數據
基準年 2025 491億美元
預計年份：2026年 529.7億美元
預測年份 2032 849.1億美元
複合年成長率 (%) 8.13%

伴侶動物獸醫學正從一次性治療轉向持續性、預防性和數據驅動的護理。寵物日益“人性化”，人們對臨床品質的期望不斷提高，以及診斷、營養、牙科、皮膚科、腫瘤科和慢性病管理服務的日益普及，都使得獸醫學的作用超越了急性病治療的範疇。

檢驗的行業指標進一步印證了這一趨勢。根據美國寵物用品協會統計，約三分之二的美國家庭飼養寵物。北美、歐洲和亞太地區的獸醫協會也持續強調對預防性護理、疫苗接種、寄生蟲防治以及老年寵物服務的需求。公共衛生組織也透過通用感染疾病預防、合理使用抗生素和負責任的動物護理，在「同一健康」框架下強調獸醫的重要性。

伴侶動物照護領域的變革性變化

人手不足、獸醫診所整合、消費者對數位化服務的期望以及寵物健康需求的日益複雜化，正在重塑伴侶動物照護產業的格局。獸醫診所正投資於自動化預約、電子健康記錄、院內診斷以及與飼主溝通的平台，以在不降低獸醫標準的前提下提高服務能力。

人工智慧在伴侶動物照護中的累積影響

人工智慧正透過影像診斷支援、分診工具、臨床記錄、預約管理、庫存管理和飼主教育等方式，開始影響伴侶動物獸醫學。同行評審的獸醫影像學研究表明，機器學習可以輔助放射學、病理學、眼科學和皮膚病學中的模式識別，但由於獸醫資料集因物種、品種、年齡、儀器類型和臨床背景而異，專家監督仍然至關重要。

伴侶動物獸醫學的關鍵區域見解

在亞太地區，都市化、可支配收入的成長以及寵物擁有率的上升，推動了中國、日本、韓國、印度和澳洲等國對高品質寵物照護的需求，進一步提升了該地區對伴侶動物獸藥的重要性。狂犬病預防、疫苗接種、進口限制以及小型動物獸醫服務的擴展也影響著這項需求。北美仍然是最成熟的伴侶動物市場之一，這得益於其較高的寵物擁有率、先進的獸醫醫院網路、專業的診所、普及的寵物保險以及在診斷、健康計劃、牙科護理和預防醫學方面的強勁支出。

伴侶動物市場整體關鍵群分析

在東協市場，尤其是在泰國、越南、印尼、菲律賓、馬來西亞和新加坡，都市區寵物飼養率的不斷提高推動了對小型動物診所、寵物營養、疫苗接種和寄生蟲預防的需求。在海灣合作理事會國家，高所得的消費者、都市化以及日益增強的動物福利意識，正在推動高階伴侶動物服務、專業診所和獸藥產品標準化進口管道的發展。

主要國家伴侶動物獸藥市場趨勢

美國憑藉其高寵物擁有率和廣泛的獸醫院網路，在全球伴侶動物消費、專業獸藥服務、先進診斷技術和寵物保險成長方面處於領先地位。在加拿大，對預防性護理、受監管的動物用藥品和伴侶動物健康服務的需求仍然強勁；而在墨西哥，隨著獸醫院、疫苗和寄生蟲預防服務的普及，都市區伴侶動物服務正在不斷擴展。巴西擁有全球最大的寵物數量之一，是疫苗、驅蟲藥、營養獸藥和小動物臨床服務的重要市場。

為伴侶動物獸醫學領域的領導者提供的實用建議。

獸藥產業的領導者在實施新技術之前，應優先考慮重新設計工作流程、確保預防性照護的依從性以及改善與飼主主人的溝通。高影響力投資包括：整合臨床管理系統、人工智慧輔助文件記錄（需經臨床醫生審核）、自動召回程序、診斷品質保證、遠端分流方案以及能夠提高寵物主人對推薦護理依從性的透明定價模式。

伴侶動物獸藥分析的調查方法。

本執行摘要是基於對經核實的公共和機構來源的二手研究，包括獸醫協會、世界動物衛生組織 (OIE)、世界衛生組織 (WHO)、聯合國糧食及農業組織 (FAO)、國家獸醫監管機構、美國食品藥物管理局(FDA) 獸醫中心、歐洲藥品管理局 (EMA)、公共動物衛生資訊來源和同行檢驗的獸醫資訊來源。

關於伴侶動物獸藥的結論

伴侶動物獸醫學正朝著更互聯、預防為主和技術驅動的方向發展。這種趨勢的促進因素包括寵物「人性化」、寵物群體老化、診斷技術的進步、人們對預防醫學日益成長的期望，以及對便利性、高品質臨床服務的需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 獸藥市場：依產品類型分類

  • 製藥
    • 抗生素
    • 殺蟲劑
    • 免疫調節劑
    • 抗病毒藥物
  • 疫苗
    • 失活
    • 減毒活病毒疫苗
    • 重組
  • 生物製劑
    • 單株抗體
    • 細胞激素
    • 生長因子

第8章 獸藥市場：依動物類型分類

  • 伴侶動物
    • 貓
    • 狗
    • 馬
    • 兔子
  • 生產動物
    • 牛
    • 家禽
    • 豬
    • 羊

第9章 獸藥市場：依產品形式分類

  • 藥片
  • 膠囊
  • 粉末
  • 液體配方

第10章 獸藥市場：依給藥途徑分類

  • 吸入
  • 注射藥物
  • 口服
  • 外用

第11章 獸藥市場：依疾病及治療分類

  • 感染疾病
    • 細菌感染疾病
    • 病毒感染疾病
    • 黴菌感染疾病
  • 寄生蟲病
  • 代謝性疾病
    • 糖尿病
    • 肥胖
    • 營養缺乏
  • 整形外科疾病
    • 關節炎
    • 斷裂
    • 關節炎
  • 皮膚症狀
    • 過敏
    • 皮膚感染疾病
  • 消化系統疾病
  • 循環系統
  • 神經病學

第12章 獸藥市場：依最終用戶分類

  • 動物醫院
  • 動物診所
  • 研究機構
  • 寵物飼主
  • 政府機構和非政府組織

第13章 獸藥市場：依通路分類

  • 線上
  • 離線

第14章 獸藥市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第15章 獸藥市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 獸藥市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • Archer-Daniels-Midland Company
  • Biogenesis Bago SA
  • Biopharm company
  • Biowet Pulawy sp. z oo
  • Brovapharma
  • CH Boehringer Sohn AG & Co KG
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Evonik Industries AG
  • Hester Biosciences Limited
  • Indian Immunologicals Ltd.
  • Intracin Pharmaceutical Private Limited
  • JoinHub Pharma
  • Merck & Co Inc.
  • Nam Pharma Sdn Bhd
  • NAPHAVET Co., Ltd.
  • Neogen Corporation
  • Nutreco NV
  • Phibro Animal Health Corporation
  • Sykes Vet International Pty Ltd.
  • TRAVETCO
  • Vetoquinol SA
  • Vetpharma Animal Health SL
  • Vetsintez LLC
  • Virbac SA
  • Weefsel Pharma
  • Zoetis Inc.
Product Code: MRR-221461476D1E

The Veterinary Medicine Market is projected to grow by USD 84.91 billion at a CAGR of 8.13% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 49.10 billion
Estimated Year [2026] USD 52.97 billion
Forecast Year [2032] USD 84.91 billion
CAGR (%) 8.13%

Veterinary medicine for companion animals is shifting from episodic treatment to continuous, preventive, and data-informed care. Rising pet humanization, higher expectations for clinical quality, and broader adoption of diagnostics, nutrition, dentistry, dermatology, oncology, and chronic disease management are expanding the role of veterinary practices beyond acute care.

Verified industry indicators support this direction. The American Pet Products Association reports that roughly two-thirds of U.S. households own a pet, while veterinary associations in North America, Europe, and Asia-Pacific continue to highlight demand for preventive care, vaccination, parasite control, and geriatric pet services. Public health agencies also emphasize the One Health relevance of veterinary medicine through zoonotic disease prevention, antimicrobial stewardship, and responsible animal care.

Transformative Shifts in the Companion Animal Care Landscape

The companion animal care landscape is being reshaped by workforce shortages, consolidation of veterinary clinics, consumer-grade digital expectations, and the increasing complexity of pet health needs. Practices are investing in appointment automation, digital medical records, in-house diagnostics, and client communication platforms to improve throughput without compromising clinical standards.

Regulation and professional guidance remain central. Veterinary telemedicine rules vary by jurisdiction, particularly around the veterinarian-client-patient relationship, while antimicrobial stewardship, controlled substance management, pharmacovigilance, and animal welfare obligations continue to influence treatment decisions. These shifts are pushing practices to balance convenience, compliance, clinical evidence, affordability, and profitability.

Cumulative Impact of Artificial Intelligence in Companion Animal Care

Artificial intelligence is beginning to affect companion animal veterinary medicine through imaging support, triage tools, clinical documentation, appointment scheduling, inventory management, and client education. Peer-reviewed veterinary imaging studies have shown that machine learning can support pattern recognition in radiology, pathology, ophthalmology, and dermatology, but professional oversight remains essential because veterinary datasets vary by species, breed, age, device type, and clinical context.

The cumulative impact of AI is likely to be operational before it becomes fully autonomous clinically. Practices can use AI to reduce administrative burden, improve follow-up consistency, flag missed preventive care opportunities, support diagnostic prioritization, and strengthen evidence-based decision-making. However, governance is required around data privacy, model validation, explainability, bias mitigation, liability, cybersecurity, and the preservation of veterinarian-led care.

Key Regional Insights for Companion Animal Veterinary Medicine

Asia-Pacific is gaining importance in companion animal veterinary medicine as urbanization, rising disposable income, and growing pet ownership support demand for premium pet care in China, Japan, South Korea, India, and Australia. Regional veterinary demand is also shaped by rabies prevention, vaccination access, import controls, and expanding small animal clinical capacity. North America remains one of the most mature companion animal markets, supported by high pet ownership, advanced veterinary hospital networks, specialty practices, pet insurance adoption, and strong spending on diagnostics, wellness plans, dentistry, and preventive medicine.

Latin America is expanding through urban pet ownership and growing access to vaccines, parasiticides, and small animal practices, with Brazil and Mexico serving as important demand centers. Europe combines high clinical standards with stringent animal welfare and medicine regulations, including EU veterinary medicine rules that shape antimicrobial use, pharmacovigilance, and product oversight. The Middle East is investing in premium pet services in affluent urban centers, supported by expatriate pet ownership and rising animal welfare awareness. Africa shows a dual-market pattern: growing companion animal care in major cities alongside persistent gaps in access, vaccination coverage, disease surveillance, and veterinary workforce density.

Key Group Insights Across Companion Animal Markets

ASEAN markets are seeing rising demand for small animal clinics, pet nutrition, vaccination, and parasite prevention as urban pet ownership increases, particularly in Thailand, Vietnam, Indonesia, the Philippines, Malaysia, and Singapore. The GCC is developing premium companion animal services, specialty clinics, and regulated import pathways for veterinary products, supported by high-income consumer segments, urbanization, and growing awareness of animal welfare.

The European Union is influential through harmonized veterinary medicine rules, animal welfare policy, pharmacovigilance requirements, and antimicrobial stewardship, making compliance critical for market access. BRICS countries combine large pet populations with uneven clinical infrastructure, creating opportunities for scalable diagnostics, vaccines, digital workflow tools, and affordable care models. G7 markets lead in specialty medicine, pet insurance, diagnostics, clinical governance, and digital health adoption, while NATO countries overlap substantially with high-regulation veterinary systems where supply chain resilience, biosecurity, medicine availability, and disease preparedness are strategic priorities.

Key Country Insights for Companion Animal Veterinary Care

The United States leads in companion animal spending, specialty veterinary services, advanced diagnostics, and pet insurance growth, supported by high pet ownership and extensive hospital networks. Canada shows strong demand for preventive care, regulated veterinary pharmaceuticals, and companion animal wellness services, while Mexico is expanding urban companion animal services as access to clinics, vaccines, and parasite prevention improves. Brazil has one of the world's large pet populations, making it a key market for vaccines, parasiticides, nutrition-linked veterinary care, and small animal clinical services.

The United Kingdom, Germany, France, Italy, and Spain are shaped by mature veterinary systems, companion animal ownership, specialty referrals, pet insurance penetration in selected markets, and EU or post-EU medicine governance. Russia remains a significant animal health market but faces supply chain and regulatory complexity. China is expanding rapidly in urban pet care, India combines rising companion animal ownership with affordability and access challenges, Japan is highly advanced in geriatric pet medicine as pets live longer, Australia emphasizes high clinical standards and biosecurity, and South Korea is growing through premium pet care, diagnostics, pet insurance interest, and digital client engagement.

Actionable Recommendations for Companion Animal Veterinary Leaders

Veterinary leaders should prioritize workflow redesign, preventive care compliance, and client communication before adding technology. High-impact investments include integrated practice management systems, AI-assisted documentation with clinician review, automated recall programs, diagnostic quality assurance, teletriage protocols, and transparent pricing models that improve adherence to recommended care.

Practices should also strengthen antimicrobial stewardship, controlled substance compliance, staff retention, mental health support, and continuing education. Suppliers and service providers can improve competitiveness by offering validated clinical tools, interoperability with veterinary records, cybersecurity controls, implementation support, and evidence-based outcomes that demonstrate time savings, diagnostic reliability, improved patient follow-up, or stronger preventive care compliance.

Research Methodology for Companion Animal Veterinary Analysis

This executive summary is based on secondary research from verified public and institutional sources, including veterinary medical associations, the World Organisation for Animal Health, the World Health Organization, the Food and Agriculture Organization, national veterinary regulators, the U.S. FDA Center for Veterinary Medicine, the European Medicines Agency, public animal health agencies, and peer-reviewed veterinary literature.

Insights were triangulated across pet ownership indicators, regulatory frameworks, veterinary workforce trends, animal health policy, antimicrobial stewardship guidance, zoonotic disease prevention priorities, and documented adoption of veterinary diagnostics, telehealth, and digital tools. Claims avoid unsupported market sizing, market share, and forecasting, focusing instead on evidence-backed directional trends relevant to veterinary medicine stakeholders.

Conclusion for Companion Animal Veterinary Medicine

Companion animal veterinary medicine is entering a more connected, preventive, and technology-enabled phase. Demand is supported by pet humanization, aging pets, expanding diagnostics, stronger preventive care expectations, and the need for accessible, high-quality clinical services.

The strongest opportunities will favor organizations that combine clinical evidence, operational efficiency, regulatory compliance, antimicrobial stewardship, and trusted client relationships. AI and digital platforms can improve productivity and continuity of care, but sustainable progress will depend on veterinarian-led governance, validated tools, privacy safeguards, and measurable improvements in patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Veterinary Medicine Market, by Product Type

  • 7.1. Pharmaceuticals
    • 7.1.1. Antibiotics
    • 7.1.2. Parasiticides
    • 7.1.3. Immunomodulators
    • 7.1.4. Antivirals
  • 7.2. Vaccines
    • 7.2.1. Inactivated
    • 7.2.2. Live Attenuated
    • 7.2.3. Recombinant
  • 7.3. Biologics
    • 7.3.1. Monoclonal
    • 7.3.2. Cytokines
    • 7.3.3. Growth Factors

8. Veterinary Medicine Market, by Animal Type

  • 8.1. Companion Animals
    • 8.1.1. Cats
    • 8.1.2. Dogs
    • 8.1.3. Horses
    • 8.1.4. Rabbits
  • 8.2. Production Animals
    • 8.2.1. Cattle
    • 8.2.2. Poultry
    • 8.2.3. Swine
    • 8.2.4. Sheep

9. Veterinary Medicine Market, by Product Form

  • 9.1. Tablets
  • 9.2. Capsules
  • 9.3. Powders
  • 9.4. Liquids

10. Veterinary Medicine Market, by Route Of Administration

  • 10.1. Inhalation
  • 10.2. Injectable
  • 10.3. Oral
  • 10.4. Topical

11. Veterinary Medicine Market, by Disease Treatment

  • 11.1. Infectious Diseases
    • 11.1.1. Bacterial Infections
    • 11.1.2. Viral Infections
    • 11.1.3. Fungal Infections
  • 11.2. Parasitic Diseases
  • 11.3. Metabolic Disorders
    • 11.3.1. Diabetes
    • 11.3.2. Obesity
    • 11.3.3. Nutritional Deficiencies
  • 11.4. Orthopedic Disorders
    • 11.4.1. Arthritis
    • 11.4.2. Fractures
    • 11.4.3. Joint Dysplasia
  • 11.5. Dermatological Conditions
    • 11.5.1. Allergies
    • 11.5.2. Skin Infections
  • 11.6. Gastrointestinal Disorders
  • 11.7. Cardiology
  • 11.8. Neurology

12. Veterinary Medicine Market, by End User

  • 12.1. Veterinary Hospitals
  • 12.2. Veterinary Clinics
  • 12.3. Research Institutes
  • 12.4. Pet Owners
  • 12.5. Government & NGOs

13. Veterinary Medicine Market, by Distribution Channel

  • 13.1. Online
  • 13.2. Offline

14. Veterinary Medicine Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. North America
  • 14.3. Latin America
  • 14.4. Europe
  • 14.5. Middle East
  • 14.6. Africa

15. Veterinary Medicine Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Veterinary Medicine Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. Archer-Daniels-Midland Company
  • 18.2. Biogenesis Bago SA
  • 18.3. Biopharm company
  • 18.4. Biowet Pulawy sp. z o.o.
  • 18.5. Brovapharma
  • 18.6. C H Boehringer Sohn AG & Co KG
  • 18.7. Ceva Sante Animale
  • 18.8. Dechra Pharmaceuticals PLC
  • 18.9. Elanco Animal Health Incorporated
  • 18.10. Evonik Industries AG
  • 18.11. Hester Biosciences Limited
  • 18.12. Indian Immunologicals Ltd.
  • 18.13. Intracin Pharmaceutical Private Limited
  • 18.14. JoinHub Pharma
  • 18.15. Merck & Co Inc.
  • 18.16. Nam Pharma Sdn Bhd
  • 18.17. NAPHAVET Co., Ltd.
  • 18.18. Neogen Corporation
  • 18.19. Nutreco NV
  • 18.20. Phibro Animal Health Corporation
  • 18.21. Sykes Vet International Pty Ltd.
  • 18.22. TRAVETCO
  • 18.23. Vetoquinol SA
  • 18.24. Vetpharma Animal Health S.L.
  • 18.25. Vetsintez LLC
  • 18.26. Virbac SA
  • 18.27. Weefsel Pharma
  • 18.28. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY MEDICINE MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL VETERINARY MEDICINE MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL VETERINARY MEDICINE MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL VETERINARY MEDICINE MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY MEDICINE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL VETERINARY MEDICINE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANTIBIOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PARASITICIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PARASITICIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL IMMUNOMODULATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL IMMUNOMODULATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL IMMUNOMODULATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANTIVIRALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANTIVIRALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANTIVIRALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INACTIVATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INACTIVATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INACTIVATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LIVE ATTENUATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LIVE ATTENUATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LIVE ATTENUATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RECOMBINANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RECOMBINANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RECOMBINANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOLOGICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOLOGICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MONOCLONAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MONOCLONAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MONOCLONAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CYTOKINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CYTOKINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CYTOKINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GROWTH FACTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GROWTH FACTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DOGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DOGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HORSES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HORSES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HORSES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RABBITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL RABBITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL RABBITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PRODUCTION ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PRODUCTION ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PRODUCTION ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SHEEP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SHEEP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SHEEP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL TABLETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL TABLETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CAPSULES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CAPSULES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CAPSULES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL POWDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL POWDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL POWDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL LIQUIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL LIQUIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL LIQUIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL INHALATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL INHALATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL INHALATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL PARASITIC DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL PARASITIC DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PARASITIC DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL DIABETES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL DIABETES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL DIABETES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL OBESITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL OBESITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL OBESITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL NUTRITIONAL DEFICIENCIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL NUTRITIONAL DEFICIENCIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL NUTRITIONAL DEFICIENCIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ORTHOPEDIC DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ORTHOPEDIC DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ORTHOPEDIC DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ARTHRITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ARTHRITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL FRACTURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL FRACTURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL FRACTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL JOINT DYSPLASIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL JOINT DYSPLASIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL JOINT DYSPLASIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL DERMATOLOGICAL CONDITIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL DERMATOLOGICAL CONDITIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL DERMATOLOGICAL CONDITIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ALLERGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ALLERGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ALLERGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL SKIN INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL SKIN INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL SKIN INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL VETERINARY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL VETERINARY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL VETERINARY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL PET OWNERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL PET OWNERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL PET OWNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL GOVERNMENT & NGOS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL GOVERNMENT & NGOS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL GOVERNMENT & NGOS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 220. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 224. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 226. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE VETERINARY MEDICINE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE VETERINARY MEDICINE MARKET SIZE, BY PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE VETERINARY MEDICINE MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE VETERINARY MEDICINE MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE VETERINARY MEDICINE MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE VETERINARY MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 250. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 252. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 254. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 256. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 258. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 260. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 262. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, 2018-2032 (USD MILLION)
  • TABLE 264. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 266. AFRICA VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 267. AFRICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. AFRICA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 269. AFRICA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 270. AFRICA VETERINARY MEDICINE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 271. AFRICA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. AFRICA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 273. AFRICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 274. AFRICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 275. AFRICA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 276. AFRICA VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 277. AFRICA VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 278. AFRICA VETERINARY MEDICINE MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 279. AFRICA VETERINARY MEDICINE MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 280. AFRICA VETERINARY MEDICINE MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, 2018-2032 (USD MILLION)
  • TABLE 281. AFRICA VETERINARY MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 282. AFRICA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 283. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 284. ASEAN VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 285. ASEAN VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. ASEAN VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 287. ASEAN VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 288. ASEAN VETERINARY MEDICINE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 289. ASEAN VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. ASEAN VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 291. ASEAN VETERINARY MEDICINE MARKET SIZE, BY PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 292. ASEAN VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 293. ASEAN VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 294. ASEAN VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 295. ASEAN VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 296. ASEAN VETERINARY MEDICINE MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 297. ASEAN VETERINARY MEDICINE MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 298. ASEAN VETERINARY MEDICINE MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, 2018-2032 (USD MILLION)
  • TABLE 299. ASEAN VETERINARY MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. ASEAN VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 301. GCC VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 302. GCC VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. GCC VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 304. GCC VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 305. GCC VETERINARY MEDICINE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 306. GCC VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 307. GCC VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 308. GCC VETERINARY MEDICINE MARKET SIZE, BY PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 309. GCC VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 310. GCC VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 311. GCC VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 312. GCC VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 313. GCC VETERINARY MEDICINE MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 314. GCC VETERINARY MEDICINE MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 315. GCC VETERINARY MEDICINE MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, 2018-2032 (USD MILLION)
  • TABLE 316. GCC VETERINARY MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 317. GCC VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 318. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 319. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 321. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 322. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 323. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 324. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 325. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 326. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 327. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 328. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 329. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 330. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 331. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 332. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, 2018-2032 (USD MILLION)
  • TABLE 333. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 334. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 335. BRICS VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 336. BRICS VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 337. BRICS VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 338. BRICS VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 339. BRICS VETERINARY MEDICINE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 340. BRICS VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 341. BRICS VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 342. BRICS VETERINARY MEDICINE MARKET SIZE, BY PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 343. BRICS VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 344. BRICS VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 345. BRICS VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 346. BRICS VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 347. BRICS VETERINARY MEDICINE MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 348. BRICS VETERINARY MEDICINE MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 349. BRICS VETERINARY MEDICINE MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, 2018-2032 (USD MILLION)
  • TABLE 350. BRICS VETERINARY MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 351. BRICS VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 352. G7 VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 353. G7 VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 354. G7 VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 355. G7 VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 356. G7 VETERINARY MEDICINE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 357. G7 VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 358. G7 VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 359. G7 VETERINARY MEDICINE MARKET SIZE, BY PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 360. G7 VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 361. G7 VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 362. G7 VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 363. G7 VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 364. G7 VETERINARY MEDICINE MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 365. G7 VETERINARY MEDICINE MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 366. G7 VETERINARY MEDICINE MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, 2018-2032 (USD MILLION)
  • TABLE 367. G7 VETERINARY MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 368. G7 VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 369. NATO VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 370. NATO VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 371. NATO VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 372. NATO VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 373. NATO VETE